Proton Capital Enters Into Agreement to Purchase PharmaChoice Canada Branded Pharmacy In Saskatoon For Proposed Qualifying Transaction
The Share Purchase Agreement provides that Proton will purchase 75% of the issued and outstanding shares of the Target Pharmacy.
- The Share Purchase Agreement provides that Proton will purchase 75% of the issued and outstanding shares of the Target Pharmacy.
- The Qualifying Transaction will not constitute a Non-Arm’s Length Qualifying Transaction (as such term is defined in the policies of the TSXV).
- The parties to the Qualifying Transaction are at arm’s length and therefore the approval of the shareholders of Proton in respect of the Qualifying Transaction will not be required.
- The Prospectus will contain important detailed information about the Corporation, the Qualifying Transaction and the proposed Offering.